Zura Bio Limited (94E.F)
EUR 1.02
(5.7%)
EUR 1.02
(5.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -99.8 Million USD | -8138.86% |
| 2022 | -1.21 Million USD | 74.33% |
| 2021 | -4.72 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -89.81 Million USD | 10.01% |
| 2024 Q2 | -188.44 Million USD | -109.81% |
| 2023 Q2 | -112.8 Million USD | -156.58% |
| 2023 Q4 | -99.8 Million USD | 3.9% |
| 2023 FY | -99.8 Million USD | -8138.86% |
| 2023 Q1 | -43.96 Million USD | 0.0% |
| 2023 Q3 | -103.85 Million USD | 7.93% |
| 2022 Q1 | -4.72 Million USD | 0.0% |
| 2022 FY | -1.21 Million USD | 74.33% |
| 2022 Q3 | -3.04 Million USD | 30.89% |
| 2022 Q2 | -4.41 Million USD | 6.53% |
| 2021 FY | -4.72 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioNTech SE | -11.44 Billion EUR | 99.128% |
| CureVac N.V. | -360.92 Million EUR | 72.347% |
| Biotest Aktiengesellschaft | 571.3 Million EUR | 117.47% |
| Biotest Aktiengesellschaft | 571.3 Million EUR | 117.47% |
| BRAIN Biotech AG | -693 Thousand EUR | -14302.02% |
| Formycon AG | 2.45 Million EUR | 4172.052% |
| Heidelberg Pharma AG | -37.6 Million EUR | -165.388% |
| Medigene AG | -5.72 Million EUR | -1643.641% |